DarioHealth (DRIO) Tops Q2 EPS by 38c

DarioHealth (NASDAQ: DRIO) reported Q2 EPS of $0.18, $0.38 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $5.37 million versus the consensus estimate of $7.12 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• Raymond James on Whirlpool Corporation (WHR): 'July Major Appliance Industrial Production Remained Weak'
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts